share_log

CBD & Hemp Company's 1013% YoY Revenue Increase, Will Raise More Money For 'Aggressive Marketing'

CBD & Hemp Company's 1013% YoY Revenue Increase, Will Raise More Money For 'Aggressive Marketing'

CBD & Hemp Company的收入同比增長1013%,將爲 “激進營銷” 籌集更多資金
Benzinga ·  2023/09/19 23:01

Endexx Corporation (OTCQB:EDXC) reported its quarterly earnings on Tuesday for the quarter ending March 31, 2023, revealing over $2.8 million in revenue compared to $254,686 in the same quarter of last year, representing a whopping 1013% year-over-year increase.

Endexx公司(場外交易代碼:EDXC)週二公佈了截至2023年3月31日的季度收益。披露超過280萬美元的收入與去年同期的254,686美元相比,這是一個驚人的數位同比增長1013%。

Todd Davis, the company's chairman and CEO, touted the quarterly results.

託德·戴維斯,該公司董事長兼首席執行官吹捧季度業績。

"Consolidating the audited financials and integrating Hyla's operations into Endexx, we've catapulted into an era marked by unprecedented growth, painting Fiscal 2023 as a canvas of resurgence and robust expansion amidst a two-year stagnation in the cannabis and hemp industry," Davis said.

戴維斯說:“整合經過審計的財務數據,並將Hyla的業務整合到Endexx,我們已經進入了一個以前所未有的增長為標誌的時代,將2023財年描繪成一幅在大麻和大麻行業停滯不前兩年的情況下復甦和強勁擴張的畫布。”

See Also: Endexx FY22 Revenue Grows 229% YoY, Here Is What You Need To Know

另請參閱:Endexx FY22財年收入同比增長229%,以下是您需要了解的內容

Quarterly Financial Highlights

季度財務亮點

  • Gross profit totaled $394,191 compared to $ 175,730 in the prior year.
  • Total operating expenses amounted to $811,200, up from $751,677 in the same quarter of fiscal 2022.
  • Loss from operations was $417,009, down from $575,947 in the same period of last year.
  • Net loss was $1.52 million, down from $2.8 million in the corresponding quarter of 2022.
  • As of March 31, the company had $155,013 in cash, down from $656,776 as of September 30, and $12.7 million in total assets, down from $13.8 million as of September 30.
  • 毛利潤總計394,191美元而上一年為175,730美元。
  • 總運營費用為811,200美元,高於2022財年同期的751,677美元。
  • 運營虧損為417,009美元,低於去年同期的575,947美元。
  • 淨虧損為152萬美元,低於2022年同期的280萬美元。
  • 截至3月31日,該公司擁有155,013美元現金,低於截至9月30日的656,776美元,以及總資產1,270萬美元低於截至9月30日的1,380萬美元。

What's Next

接下來是什麼?

The management's plans include the "sustained and aggressive marketing of hemp cannabidiol products and raising additional capital through sales of equity or debt securities as may be necessary to pursue its business plans and sustain operations until such time as the company can achieve profitability," the company said in filing with the U.S. Securities and Exchange Commission (SEC).

該公司在提交給美國證券交易委員會(SEC)的檔案中表示,管理層的計劃包括“持續積極地營銷大麻二醇產品,並通過出售股權或債務證券籌集額外資金,以實施其業務計劃並維持運營,直到公司能夠實現盈利。”

The company develops hemp-derived, cannabidiol-based products through its CBD Unlimited subsidiary.

該公司通過其CBD無限子公司開發大麻衍生的以大麻二醇為基礎的產品。

To learn more about cannabis companies and their financial performance, come join us at the upcoming Benzinga cannabis event in Chicago.

要了解更多關於大麻公司及其財務業績的資訊,請加入我們即將舉行的芝加哥的Benzinga大麻事件。

The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Benzinga Cannabis Capital Conference是達成交易的地方,將於今年9月27日至28日返回芝加哥舉行第17屆。在價格上漲之前今天就買到票,並在大麻投資和品牌推廣的中心獲得一席之地。

Photo: Courtesy of Hvoenok and GOR Photo on Shutterstock

圖片提供:Hvoenok和Gor在Shutterstock上的照片

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論